Wei Liu

ORCID: 0000-0002-4343-3151
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Galectins and Cancer Biology
  • Toxin Mechanisms and Immunotoxins
  • Signaling Pathways in Disease
  • Peptidase Inhibition and Analysis
  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmaceutical Practices and Patient Outcomes
  • Nanoplatforms for cancer theranostics
  • Nanoparticle-Based Drug Delivery
  • Immune Cell Function and Interaction
  • vaccines and immunoinformatics approaches
  • Drug Transport and Resistance Mechanisms
  • Natural product bioactivities and synthesis
  • Pharmaceutical studies and practices
  • Immunotherapy and Immune Responses
  • Glycosylation and Glycoproteins Research
  • Advanced Drug Delivery Systems
  • Pharmaceutical Economics and Policy
  • Supramolecular Self-Assembly in Materials
  • Protease and Inhibitor Mechanisms
  • Microbial Applications in Construction Materials
  • Traditional and Medicinal Uses of Annonaceae
  • Drug Solubulity and Delivery Systems
  • Traditional Chinese Medicine Analysis
  • Phytochemistry and Biological Activities
  • Micro and Nano Robotics

Zhengzhou University
2010-2024

Ministry of Education of the People's Republic of China
2022

Chinese Center For Disease Control and Prevention
2022

Central South University
2019

Zhengzhou Children's Hospital
2019

Shenyang Pharmaceutical University
2007-2018

University of California, Davis
2012

Nanchang University
2011

First Affiliated Hospital of Nanchang University
2011

Harbin Medical University
2009

Multidrug resistance (MDR) of a tumor is the main cause failure clinical chemotherapy. Herein, we report simple, yet versatile, tumor-targeting "calcium ion nanogenerator" (TCaNG) to reverse drug by inducing intracellular Ca2+ bursting. Consequently, TCaNG could induce bursting in acidic lysosomes cells and then according following mechanisms: (i) specifically accumulates mitochondria, suppressing cellular respiration relieving hypoxia, thus inhibiting P-glycoprotein biosynthesis...

10.1021/acs.nanolett.0c03042 article EN Nano Letters 2020-10-16

Oral drug delivery systems have great potential to treat colorectal cancer (CRC). However, the efficiency is restricted by limited CRC-related intestine positioning and dense mucus barrier. Here, we present a biological chemotaxis-guided self-thermophoretic nanoplatform that facilitates precise intestinal autonomous penetration. The introduces asymmetric platinum-sprayed mesoporous silica achieve movement in mucus. Furthermore, inspired intense interaction between pathogenic microbes CRC,...

10.1126/sciadv.abn3917 article EN cc-by-nc Science Advances 2022-06-29

Targeted drug delivery to colon cancer cells can significantly enhance the therapeutic efficiency. Herein, we developed 5-fluorouracil (5-FU)-loaded amino-functionalized mesoporous silica nanoparticle (MSN-NH2)-based galactosylated chitosans (GCs), which are galactose receptor-mediated materials for colon-specific systems. Both unmodified and functionalized nanoparticles were characterized by scanning electron microscopy, transmission X-ray diffraction, Fourier transform infrared...

10.1098/rsos.181027 article EN cc-by Royal Society Open Science 2018-12-01

5-Aminolevulinic acid (5-ALA) has been approved for clinical photodynamic therapy (PDT) due to its negligible photosensitive toxicity. However, the curative effect of 5-ALA is restricted by intracellular biotransformation inactivation and potential DNA repair tumor cells. Inspired crucial function iron ions in transformation repair, a liposomal nanomedicine ([email protected]/DFO) with ion regulation property was developed boosting PDT 5-ALA, which prepared co-encapsulating DFO...

10.1016/j.apsb.2021.03.017 article EN cc-by-nc-nd Acta Pharmaceutica Sinica B 2021-04-29

Nirmatrelvir/ritonavir is approved for the treatment of adults and pediatric patients with mild to moderate COVID-19, but information on adverse events associated its use limited. We aim evaluate potential risk nirmatrelvir/ritonavir using FDA Adverse Event Reporting System (FAERS). Disproportionality analysis was performed reporting odds ratio (ROR) method, subset based patient age gender, as well sensitivity restricting type reporter healthcare professionals. most commonly reported...

10.3390/ph15121455 article EN cc-by Pharmaceuticals 2022-11-24

Targeted drug delivery to colon cancer cells can significantly improve the efficiency of treatment. We firstly synthesized carboxyl-modified mesoporous silica nanoparticles (MSN⁻COOH) via two-step synthesis, and then developed calcium leucovorin (LV)-loaded based on galactosylated chitosan (GC), which are galectin receptor-mediated materials for colon-specific systems. Both unmodified functionalized were characterized by scanning electron microscopy (SEM), transmission microscope (TEM),...

10.3390/molecules23123082 article EN cc-by Molecules 2018-11-26

Direct factor Xa inhibitors rivaroxaban, apixaban, and edoxaban, commonly used direct oral anticoagulant (DOAC), are widely to prevent treat stroke venous thromboembolic events in patients with atrial fibrillation (AF). This study aimed assess compare reports of adverse associated including hemorrhagic non-hemorrhagic events.

10.1080/14740338.2024.2368815 article EN Expert Opinion on Drug Safety 2024-06-18

A novel method, named as the plasma protein-interaction QSAR analysis (PPI-QSAR) was used to construct models for human protein binding. The intra-molecular descriptors of drugs and inter-molecular interaction resulted from docking simulation between drug molecules serum albumin were included independent variables in this method. structure-based silico model a data set 65 antibiotic constructed by multiple linear regression method validated residual analysis, normal Probability-Probability...

10.1002/bdd.762 article EN Biopharmaceutics & Drug Disposition 2011-07-29

The use of chemotherapy combined with photothermal therapy (PTT) is getting a focus topic for cancer treatment. Duing this research, the double targeting drug delivery system nedaplatin (NDP)–carboxyl-functionalized magnetic mesoporous silica (MMSN-COOH)–galactosylated chitosan (GC) nanoparticles (NPs) was constructed. Because MMSNs have special physical properties, it can target to specific area. In addition, it’s able convert absorbed near-infrared (NIR) light into heat energy (PTT)....

10.1166/jnn.2021.19142 article EN Journal of Nanoscience and Nanotechnology 2021-03-11

Background: Th immune response plays an important role in Helicobacter pylori (H. pylori) infection. Tim-1 and Tim-3 are expressed on terminally differentiated Th2 Th1 cells, respectively, participate the regulation of response. Until now, Tim H. infection remains unclear. Materials Methods: (1) Lymphocytes isolated from spleen BALB/c mice were co-cultured with different concentrations viable pylori. Alternatively, challenged by to set up model. (2) The expression mRNA level lymphocytes or...

10.1111/j.1523-5378.2011.00855.x article EN Helicobacter 2011-09-19

Gelatin has been considered to exist as intermediate substance of collagen catabolism in tissue remodeling or under inflammatory conditions. We have initiated the study on possible biological functions gelatin that can temporally and locally conditions inflammation Materials methods: To this purpose, we investigated cell proliferation survival gelatin-coated dishes response tumor necrosis factor α (TNFα)-induced cytotoxicity L929 cells. Autophagy level, ATP ROS generation are examined.L929...

10.3109/03008207.2016.1146713 article EN Connective Tissue Research 2016-03-31

The elemene-type terpenoids, which possess various biological activities, contain a syn- or anti-1,2-dialkenylcyclohexane framework. An efficient synthetic route to the and core its application in synthesis of (±)-geijerone diastereomer is reported. Construction anti-1,2-dialkenyl moiety was achieved via Ireland-Claisen rearrangement (E)-allylic ester, cyclohexanone derived from iodoaldehyde intramolecular Barbier reaction. strategy allows rapid access epimers analogues products.

10.3390/molecules19011238 article EN cc-by Molecules 2014-01-20
Coming Soon ...